Surveillance for antiviral-agent-resistant herpes simplex virus in the general population with recurrent herpes labialis

被引：37

作者：

Bacon, TH

Boon, RJ

Schultz, M

Hodges-Savola, C

机构：

[1] GlaxoSmithKline Consumer Healthcare, Weybridge KT15 0DE, Surrey, England

[2] GlaxoSmithKline, Res Triangle Pk, NC 27709 USA

[3] ViroMed Inc, Minneapolis, MN 55343 USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2002年 / 46卷 / 09期

关键词：

D O I：

10.1128/AAC.46.9.3042-3044.2002

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

In a general population survey in the United States, the prevalence of antiviral-agent-resistant herpes simplex virus was very low among more than 1,000 isolates from individuals with an episode of recurrent herpes labialis not treated with topical antiviral agents. Two isolates had borderline resistance to acyclovir (0.2%), and all were susceptible to penciclovir.

引用

收藏

页码：3042 / 3044

页数：3

相关论文

共 9 条

[1] Antiviral susceptibilities of herpes simplex virus from immunocompetent subjects with recurrent herpes labialis: a UK-based survey [J].

Boon, RJ ;

Bacon, TH ;

Robey, HL ;

Coleman, TJ ;

Connolly, A ;

Crosson, P ;

Sacks, SL .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (02) :324-325

[2] Survey of resistance of herpes simplex virus to acyclovir in northwest England [J].

Christophers, J ;

Clayton, J ;

Craske, J ;

Ward, R ;

Collins, P ;

Trowbridge, M ;

Darby, G .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (04) :868-872

[3]

COLLINS P, 1993, J MED VIROL, P58, DOI 10.1002/jmv.1890410512

[4] Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: A multicenter, randomized, placebo-controlled trial [J].

Sacks, SL ;

Thisted, RA ;

Jones, TM ;

Barbarash, RA ;

Mikolich, DJ ;

Ruoff, GE ;

Jorizzo, JL ;

Gunnill, LB ;

Katz, DH ;

Khalil, MH ;

Morrow, PR ;

Yakatan, GJ ;

Pope, LE ;

Berg, JE .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2001, 45 (02) :222-230

[5] CORRELATION BETWEEN RESPONSE TO ACYCLOVIR AND FOSCARNET THERAPY AND IN-VITRO SUSCEPTIBILITY RESULT FOR ISOLATES OF HERPES-SIMPLEX VIRUS FROM HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS [J].

SAFRIN, S ;

ELBEIK, T ;

PHAN, LH ;

ROBINSON, D ;

RUSH, J ;

ELBAGGARI, A ;

MILLS, J .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (06) :1246-1250

[6] Perspectives on switching oral acyclovir from prescription to over-the-counter status: Report of a consensus panel [J].

Sande, MA ;

Armstrong, D ;

Corey, L ;

Drew, WL ;

Gilbert, D ;

Moellering, RC ;

Smith, LG .

CLINICAL INFECTIOUS DISEASES, 1998, 26 (03) :659-663

[7] Penciclovir cream for the treatment of herpes simplex labialis - A randomized, multicenter, double-blind, placebo-controlled trial [J].

Spruance, SL ;

Rea, TL ;

Thoming, C ;

Tucker, R ;

Saltzman, R ;

Boon, R .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (17) :1374-1379

[8]

Swierkosz Ella M., 1995, P1415

[9]

VELTRI JC, IN PRESS PHARMCOEPID